MedPath

Treatment of osteochondral defects of the talus by arthroscopic debridement and microfracturing: Long term follow-up

Conditions
10005944
osteochondral defect
defect of bone and cartilage
10043237
Registration Number
NL-OMON32419
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Patients with an osteochondral defect of the talus, who have been treated by means of arthroscopic debridement and microfracturing between 1988 and 2000.

Exclusion Criteria

Other surgical treatment of osteochondral defect of the talus (fixation, osteochondral autologous transplantation, autologous chondrocyte implantation), systemic disease (e.g. rheumatoid arthritis, lupus erythemadosus), inability to understand the patient information and the questionnaires (e.g. mental retardation, language barrier), ankle trauma 6 months or less before follow-up.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome measure is the subjective outcome of the patients, measured<br /><br>by the Berndt & Harty Outcome score and the Ogilvie-Harris score.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures are the AOFAS-AHS score, the SF-36 score,<br /><br>classification of OCDs of the talus and osteoarthritis. </p><br>
© Copyright 2025. All Rights Reserved by MedPath